Vielen Dank für Ihre Anfrage.
Wir werden Sie innerhalb weniger Werktage kontaktieren.
(Geschäftseinheit Performance Materials, Sales Support Team)
Gebäude AIA Central, Ebene 39, Jl. Jend. Sudirman Kav. 48A, Jakarta Selatan, Indonesien
+62 21 2988 8557
Erfolg! Ihre Anfrage wurde an unser Vertriebsteam übermittelt.
Etwas ist schiefgelaufen! Bitte versuchen Sie es später erneut.
Wir haben 129 Elemente gefunden.
| Kontaktdaten des Antragstellers | |
| Vollständiger Name | |
| Unternehmen | |
| Position | |
| Telefonnummer | |
| Geschäftliche E-Mail-Adresse | |
| Lieferadresse | |
Thank you. Your request has been sent.
CITICOLINE SODIUM is a novel nutrient with a broad spectrum of benefits for conditions associated with symptoms of neurological dysfunction shows promise of clinical efficacy in elderly patients with cognitive deficits, inefficient memory, and early-stage Alzheimer's disease.
**Product Overview: Febuxostat – A Robust Solution for Gout Management** Refarmed Chemicals presents Febuxostat, a meticulously prepared medication aimed at alleviating the pain and discomfort associated with gout. Made from a refined white powder, Febuxostat stands out in the pharmaceutical industry as a Xanthine Oxidase Inhibitor, crucial for managing hyperuricemia and recurrent gout attacks. Structured to meet corporate expectations, Febuxostat is a testament to Refarmed Chemicals' 30-year expertise in delivering quality generic and branded medications. Manufactured in compliance with strict guidelines, including the Drug Master File (DMF) and certifications such as WC and GMP, this product is a model of reliability and efficacy. Febuxostat's fundamental use is to decrease blood uric acid levels, offering those afflicted with gout a pathway to recovery by preventing acute flare-ups, and mitigating inflammation and pain in the joints. As a white, soluble powder, Febuxostat is highly soluble in DMSO and slightly soluble in methanol and water, simplifying its integration into diverse medical formulations. Clinical trials have informed a standard starting dosage of 40 mg, adjustable up to 80 mg based on individual patient requirements and the severity of symptoms. In its commitment to patient welfare, Refarmed Chemicals underlines potential side effects ranging from nausea and headaches to rashes, ensuring informed usage of Febuxostat. In alignment with our promise of transparency and safety, we advise consulting healthcare professionals for precise diagnotics and treatment plans. Furthermore, users should be attentive to contraindications, noting that Febuxostat is unsuitable for patients with severe liver or kidney disease, or for women who are pregnant or breastfeeding. Refarmed Chemicals' Febuxostat exceeds industry standards with its impressive assay value of 98.0% - 102.0% purity and a precise control of impurities, ensuring that the product meets stringent quality criteria. The company's analytical rigor is reflected in the detailed specification of residual solvents such as Acetone, Ethanol, and Isopropanol. In the journey to deliver improved health outcomes, Refarmed Chemicals' Febuxostat is more than just a medication; it symbolizes our dedication to quality, safety, and corporate responsibility in the global pharmaceutical landscape. [*Note: Product image depicts a detailed specification chart for Febuxostat, reiterating its quality and compositions.*]
Products still subject to third-party patent protection might be available solely for R&D purposes.
Nadifloxacin: Advanced Antibacterial Solution Refarmed Chemicals presents Nadifloxacin, an efficacious fluoroquinolone antibiotic designed for the assured treatment of various bacterial infections. With its potent broad-spectrum activity, Nadifloxacin offers healthcare professionals a robust option for combating Gram-negative and Gram-positive bacteria, that are often responsible for conditions such as urinary tract infections (UTIs), skin and soft tissue infections, respiratory tract infections, and certain sexually transmitted infections (STIs). Nadifloxacin's pharmacological profile indicates it is generally administered orally via tablets or suspension, with dosing regimens from 500-1000 mg every 12 hours, though this may adjust based on infection severity and individual patient requirements. This medication underscores its commitment to quality and safety, presenting a product that is white to yellowish in crystalline powder form, ensuring high purity with an assay value of ≥ 99.0%. Made with stringent adherence to Good Manufacturing Practice (GMP) standards, Nadifloxacin is both soluble and stable in various solvents, including sodium hydroxide TS and N,N-dimethylformamide (DMF), offering versatile formulation options. Its melting point ranges from 246-250°C, emphasizing its stability under a broad spectrum of conditions. Clarity and color of the solution are maintained as clear, colorless to slight yellow, with stringent checks on impurities – including heavy metals and arsenics kept to minimum levels, aligning with industry standards. While side effects can include nausea, vomiting, diarrhea, and other conditions, they are closely monitored, ensuring optimal patient safety. Patients with hypersensitivity, seizure histories, or on interfering medications are advised to avoid this product and consult healthcare professionals. Nadifloxacin's efficacy is matched only by Refarmed Chemicals' attention to detail and commitment to patient health. With transparent documentation and certification, consumers are assured of the product's integrity, supplemented by the comprehensive information provided by the DKSH Group to facilitate informed decision-making. As a corporate customer looking to source reliable antibiotics, Nadifloxacin represents a high-grade pharmaceutical ingredient that stands for efficacy and safety in the management of bacterial infections.
Products still subject to third-party patent protection might be available solely for R&D purposes.
Atorvastatin Calcium, provided by Refarmed Chemicals, is a potent pharmaceutical ingredient used by healthcare professionals in the management and prevention of several cardiovascular-related conditions. As an integral part of the statin class of medications, Atorvastatin Calcium serves a critical role in reducing cholesterol levels, specifically low-density lipoprotein (LDL) cholesterol, apolipoprotein B, and total cholesterol. It is also effective in lowering triglyceride levels and is indicated for the prevention of cardiovascular events such as ischemic strokes and transient ischemic attacks, particularly in patients who are at high risk of these events. This product is especially valuable for the treatment of familial heterozygous and homozygous hypercholesterolemia. However, it is contraindicated in individuals with known hypersensitivity to the active ingredient, those suffering from active liver disease, and should not be used during pregnancy and breastfeeding due to potential risks. Formulated as a white or almost white yellowish crystalline powder, Atorvastatin Calcium comes with comprehensive documentation and certifications, such as the Certificate of Suitability (CEP) and Good Manufacturing Practice (GMP) standards, ensuring its quality and safety. The material's purity is rigorously controlled, with an assay requirement of 98.0% to 102.0%, minimal water content, and strict limits on enantiomer impurities as well as residual solvents such as Methanol and Methyl tert-butyl ether, as specified in the provided image of its typical properties. Patients prescribed Atorvastatin Calcium should be under close medical supervision to monitor liver function and signs of muscle damage, a potential adverse effect. Muscle pain, diarrhea, nausea, headache, and flatulence are among the commonly reported side effects. Moreover, Atorvastatin Calcium can interact with several other medications, necessitating careful review by healthcare professionals when determining a patient's regimen. Refarmed Chemicals' rigorous adherence to quality and patient safety, as exemplified by their Atorvastatin Calcium product, fulfills the expectation of effectiveness and reliability desired by healthcare providers and wholesalers looking to distribute a product that can make a significant impact on public health.
Products still subject to third-party patent protection might be available solely for R&D purposes.